Spondyloarthritis & psoriatic arthritis

WTAP regulates PTEN through m6A methylation to modulate the inflammatory response in CD4+ T cells from patients with ankylosing spondylitis

Clin Exp RheumatolPublished case-control study and cellular experiments

Authors' conclusion

In conclusion, WTAP downregulation promotes AS inflammation by decreasing PTEN expression through an m6A-dependent mechanism.

Study context

Population
Ankylosing spondylitis (AS) patients and age- and gender-matched healthy controls; CD4+ T lymphocytes from peripheral venous blood; WTAP-knockdown model in human Jurkat T cells45 AS patients and 45 healthy controls
Participants
45 vs 45
Comparison
AS patients compared to healthy controls; WTAP knockdown in Jurkat T cells
  • AS PATIENTSn = 45
  • HEALTHY CONTROLSn = 45
Outcome
WTAP and PTEN expression levels in CD4+ T lymphocytes
Methodological detailsage- and gender-matched
  • Age- and gender-matched

Main finding

As reported in the abstract

  • Significantly downregulated in AS patients compared to healthy controls

Observational data: associations, not effects.

Further findings

Correlation of WTAP and PTEN with TNF-α levels

Both inversely correlated with TNF-α levels

PTEN expression, PTEN m6A modification and TNF-α expression after WTAP knockdown in Jurkat T cells

Marked decrease in both PTEN expression and its m6A modification, coinciding with a significant increase in TNF-α expression

Original publication

WTAP regulates PTEN through m6A methylation to modulate the inflammatory response in CD4+ T cells from patients with ankylosing spondylitis. Clin Exp Rheumatol. Published 30 June 2026. doi:10.55563/clinexprheumatol/crvq7p

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.